Figure S1 from Leveraging Commercially Available Protein Assays as Biomarkers for Lung Cancer
Year: 2026
Type: other
Abstract: Study flow diagram of the process for prospective specimen collection on the internal training, external testing, and external validation cohorts, in addition to the subsequent biomarker measurement and analysis.
Authors: Kevin Connor McGann, Palina Woodhouse, Heidi Chen, Michael N. Kammer, Hudson Michael Holmes, Camden Lopez, Harvey I. Pass, Jun-Chieh J. Tsay, Marc E. Lenburg, Steven M. Dubinett, James C. Willey, James G. Herman, Matthew B. Schabath, Timothy A. Khalil, Yong Zou, Melissa H. Potter, Sheau-Chiann Chen, Samson A. Argaw, Patrick Meyers, Sam Fischer, Carolyn Tran, Yency J. Forero, Sanja Antic, Rafael Paez, Eardi Lila, Anna E. Barón, Fabien Maldonado, Stephen A. Deppen, Eric L. Grogan
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7166856776
Cites:
Cited by:
Related to: